Phosphagenics CEO steps down
Dr Esra Ogru, CEO of Phosphagenics (ASX: POH), handed in her resignation as a director of the company effective as of last Thursday 18 July 2013.
The Phosphagenics board suspended Esra Ogru on 1 July, after it discovered apparent irregular transactions in the company’s invoicing and accounting records.
The company expects to announce the key findings of an independent investigation on Wednesday 24 July 2013.
Phosphagenics’ shares were trading at $0.105 at about 3 pm on Monday.
Indigenous-led initiative to resurrect the South Island Giant Moa
New Zealand's Ngāi Tahu Research Centre has partnered with Colossal Biosciences and Sir Peter...
Abnormal brain protein targeted in Parkinson's study
Researchers have identified a new brain protein involved in the development of Parkinson's...
Epilepsy disease model treated in a laboratory dish
A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...